A detailed history of Quadcap Wealth Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Quadcap Wealth Management, LLC holds 7,272 shares of CRSP stock, worth $367,890. This represents 0.07% of its overall portfolio holdings.

Number of Shares
7,272
Previous 7,299 0.37%
Holding current value
$367,890
Previous $497 Million 21.05%
% of portfolio
0.07%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$51.17 - $68.18 $1,381 - $1,840
-27 Reduced 0.37%
7,272 $393 Million
Q1 2024

May 10, 2024

SELL
$60.67 - $89.12 $126,618 - $185,993
-2,087 Reduced 22.24%
7,299 $497 Million
Q4 2023

Feb 14, 2024

BUY
$38.62 - $72.18 $362,487 - $677,481
9,386 New
9,386 $588 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.95B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Quadcap Wealth Management, LLC Portfolio

Follow Quadcap Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadcap Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadcap Wealth Management, LLC with notifications on news.